Health
EU regulator probes possible kidney damage from coronavirus drug – Macau Business
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir, made by US pharma giant Gilead.
The European Medicines Agency recommended the use of the anti-viral drug, sold under the brand name Veklury, in June after studies showed it could reduce the length of hospital stays for Covid-19 sufferers.
“EMA’s safety committee has started a review… to assess reports of acute kidney injury in some patients …
-
Noosa News18 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News22 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News23 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General23 hours agoJim Chalmers will have to juggle competing demands to secure tax reform